A33T (p.Ala33Thr) variant of DRD3 (Dopamine receptor D3)

A33T (p.Ala33Thr) in DRD3 (Dopamine receptor D3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.70 / 1. The record also includes structural context.

A33T (p.Ala33Thr) variant details